The story behind Dr. Paul's is rooted in science and friendship. Earlier in his career Dr. Paul taught as a professor at two of the world's top medical schools, where he led a research lab that developed potential new treatments for brain diseases. In 2011, his research group made the seminal observation that chronic brain diseases, such as Alzheimer's disease, could potentially be treated by targeting the peripheral immune system (Zwilling et al.). In his quest to identify new pathways in immune cells that might be important for brain diseases, Dr. Paul decided to investigate the endocannabinoid system (the body's endogenous cannabinoid system). In 2012 his research group made the remarkable discovery that this system, acting in circulating immune cells, is a critical determinant of the onset and severity of neurodegeneration (Bouchard et al.). At this point in time Dr. Paul became obsessed with understanding the molecular basis for how cannabis might exert all of its fascinating effects, including its medical benefits. After scrutinizing thousands of research studies, Dr. Paul had the Epiphany that strong scientific evidence supports the hypothesis that terpenes are critical players in all of the actions of cannabis, and that the manipulation of terpene levels might result in cannabis products with discrete, reproducible effects. Dr. Paul shared his ideas with a number of successful friends with unique entrepreneurial backgrounds, and with their encouragement and investment, Dr. Paul's was launched in 2016. Dr. Paul's is a company that is rooted in science, and its core uses research based product development to create unique and exciting vape pen cartridges.
Paul Muchowski, PhD
Paul Muchowski currently serves as the CEO and CSO for Dr. Paul's. Dr. Paul received a PhD in Biological Structure from the University of Washington and performed post-doctoral training at the Max Planck Institute for Biochemistry. Dr. Paul worked as a professor in medical schools at the University of Washington and the University of California San Francisco, and subsequently in drug development in the pharmaceutical and biotech industries. Dr. Paul is a leading expert on neurodegenerative diseases, has published >60 highly cited research papers, has given hundreds of lectures on his research worldwide, and has won numerous awards for his innovative research and leadership. Dr. Paul currently serves as co-chair of the Scientific Advisory Committee for the National Cannabis Industry Association.
Listen to an interview on Cannabis Radio where Dr. Paul talks about The Molecular Basis of Neurodegenerative Diseases
Join Dr. Paul at the NCIA conference in Denver on February 7-8, 2018. He will review what we know about terpenes and the entourage effect and how this may influence the biological effects of cannabis.
Kevin Muchowski is a Professional Engineer with a Bachelor of Applied Science degree in Industrial Systems Engineering from the University of Regina. He has over 20 years of facility/process systems engineering and management experience. Mr. Muchowski is currently employed by a mid size energy company in Calgary, Alberta Canada. His primary responsibilities are researching and implementing innovative cost effective energy process systems. He has been involved in research on multiphase flow, CO2 extraction, cogeneration and waste heat recovery. He is known for out of the box thinking and implementing unique solutions.
Dr. Paul’s Xanadu Vape Pen Review (Terpenes and Testing Magazine) - When it comes to vaping Dr. Paul’s Xanadu, expect a rich experience both in the flavor and effects...